Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Anebulo Pharmaceuticals, Inc. (ANEB)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsMar-31-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-K10-Q10-Q10-Q10-K10-Q
Net income   -6.8-33.6-40.5-39.8-38.5-9.5
Stock-based compensation   0.50.40.30.20.2 
Change in working capital   [+] 0.9-0.3-1.0-0.9-1.4 
Other operating activities       34.8 
Cash from operations   -5.4-6.9-6.3-5.5-4.9 
   
Capital expenditures   0.00.00.00.00.0 
Cash from investing   0.00.00.00.00.0 
   
Issuance of common stock, net       20.6 
Other cash from financing       1.2 
Cash from financing   0.020.221.821.821.8 
   
Free cash flow   -5.4-6.9-6.3-5.5-4.9 
        Per share (diluted)   ($0.23)($0.33)($0.34)($0.35)($0.38) 
   
Cash paid for interest        0.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy